Transaction in Own Shares

RNS Number : 8053G
Plaza Centers N.V.
28 October 2008
 



28 October 2008


Plaza Centers N.V. 

('Plaza' or the 'Company')


MARKET PURCHASE OF OWN SHARES


Plaza Centers, a leading emerging markets property developer, today announces that, pursuant to an authority granted by the shareholders at the Annual General Meeting on 27 May 2008 to make market purchases of its own shares, Plaza purchased 154,567 shares yesterday at prices between 40 Pence and 42 Pence per share. The purchased shares will all be held as treasury shares. 


Following the purchase of these shares the number of shares with voting rights in issue (excluding shares held in treasury) will be 289,373,370 and the number of shares in treasury will be 3,058,011.



ENDS


For further details please contact:


Plaza

Mordechay Zisser, Chairman

Ran Shtarkman, President and CEO

Roy Linden, CFO

+972 3 6086000

+36 1 462 7221

+36 1 462 7105


Financial Dynamics

Stephanie Highett/Laurence Jones

+44 20 7831 3113



Notes to Editors

Plaza Centers N.V. (www.plazacenters.com) is a leading emerging markets developer of shopping and entertainment centres. It focuses on constructing new centres and, where there is significant redevelopment potential, redeveloping existing centres in both capital cities and important regional centres. The Company is dual listed on the Main Board of the London Stock Exchange and, as of 19 October 2007, the Warsaw Stock Exchange (LSE:'PLAZ', WSE: 'PLZ/PLAZACNTR'). Plaza Centers N.V. is an indirect subsidiary of Elbit Imaging Ltd. ('EIL'), an Israeli public company whose shares are traded on both the Tel Aviv Stock Exchange in Israel and the NASDAQ Global Market in the United States.


Plaza Centers is a member of the Europe Israel Group of companies which is controlled by its founder, Mr. Mordechay Zisser. It has been active in real estate development in emerging markets for over 12 years.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
POSFEMFUWSASEES
UK 100

Latest directors dealings